Dr. Lohmer has been with Nuventra for 3+ years and has experience in all stages of development, with specific interest in Pediatric Study Plans and Concentration-QT analyses. Dr. Lohmer has also worked on 3 approved drugs, NDAs, INDs, a variety of other regulatory submissions, PK analyses, and Population PK analysis.
Education